JETEMA, Co., Ltd. announced that it has received KRW 70 billion in funding from Brain Asset Management Co., Ltd., Kiwoom Securities Co., Ltd., Investment Arm, eBest Investment Securities Co., Ltd., Investment Arm, Axis Investment Co., Ltd., Mirae Asset Securities Co., Ltd., Shinhan Capital, Investment Arm and other investors
July 07, 2021
Share
On July 7, 2021, JETEMA, Co., Ltd. closed the transaction.
JETEMA. CO,.LTD is a Korea-based company principally engaged in the development and manufacturing of hyaluronic acid fillers used for facial beauty and other medical devices. The Company manufactures and sells medical devices for improvement of wrinkle, contour and volume. In addition, the Company also engages in the manufacturing and sale of laser equipment used for treatment of leukoplakia, psoriasis and alopecia areata, lifting medical device epiticons, cosmetic mask packs, pharmaceutical excaine creams as well as others.
JETEMA, Co., Ltd. announced that it has received KRW 70 billion in funding from Brain Asset Management Co., Ltd., Kiwoom Securities Co., Ltd., Investment Arm, eBest Investment Securities Co., Ltd., Investment Arm, Axis Investment Co., Ltd., Mirae Asset Securities Co., Ltd., Shinhan Capital, Investment Arm and other investors
JETEMA, CO., LTD. 
